VVTM — VVT Med Cashflow Statement
0.000.00%
Last trade - 00:00- CA$21.42m
- CA$21.18m
Annual cashflow statement for VVT Med, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Net Income/Starting Line | 4.62 | -0.194 | -0.106 | -0.136 | -0.115 |
| Depreciation | |||||
| Non-Cash Items | -5.13 | 0 | — | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.142 | 0.058 | 0.02 | 0.067 | 0.042 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.312 | -0.135 | -0.086 | -0.069 | -0.073 |
| Capital Expenditures | -0.004 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.004 | 0 | — | — | — |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | — | — | — |
| Financing Cash Flow Items | -0.045 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.223 | 0.092 | 0.085 | 0.074 | 0.073 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.089 | -0.043 | -0.002 | 0.005 | 0 |